RE: Hepatocellular liver cancer modalities [00014] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

RE: Hepatocellular liver cancer modalities



I am attaching a reply I made to an inquiry about HCC made on Cancer-l mail 
list. Please feel free to contact me by direct e-mail if you wish.

Welcome to the list Mike. You didn't give us much to go on except 
"inoperable." I was diagnosed in Sept. '95 with Hepatocellular Carcinoma 
(Hepatoma) and told by my GI doc to enjoy what time I had left - 2 to 6 
months. The NCI literature is even more depressing. I had cryosurgery last 
month and was declared cancer free when I left the hospital. There are many 
many details I'd be glad to share with you as well as the results of 
exhaustive research I did on the net and other sources. Even if you have 
multiple tumors cryosurgery can be used in many cases to make the condition 
operable conventionally. There are several options to consider but it is 
important to act quickly as HCC is a  fast growing cancer. Do you know what 
stage your cancer is - is it unifocal (one tumor) or multicentric - what 
are the measurements of your tomor(s) - why is it considered inoperable - 
is it near or around an artery or bile ducts - is it complicated by 
cirrhosis or hepatitis - have you had a second AND a third opinion - 
cryosurgery to the liver is new and is not available in all parts of the 
country yet, some doctors are not even aware of it - how is your health 
otherwise? These things are all important to know to point in the right 
direction.Let me assure you that  you are in the right place on the list - 
there are many wonderful caring people here to offer information and 
support. Don't let your "First Try" be your last, let us hear from you 
again.

Bud



----------
From: 	LoginName[SMTP:LoginName@mcn.org]
Sent: 	Wednesday, January 24, 1996 4:43 PM
To: 	mol-cancer@linux.kbt.com
Subject: 	Hepatocellular liver cancer modalities

Please inform me of alternative modalities and treatments for
hepatocellular primary liver cancer with possible metastasies to lower
right lobe the lung.







begin 600 WINMAIL.DAT
M>)\^(C$-`0:0" `$```````!``$``0>0!@`(````Y 0```````#H``$-@ 0`
M`@````(``@`!!) &`#0!```!````# ````,``# #````"P`/#@`````"`?\/
M`0```$\`````````@2L?I+ZC$!F=;@#=`0]4`@````!M;VPM8V%N8V5R0&QI
M;G5X+FMB="YC;VT`4TU44 !M;VPM8V%N8V5R0&QI;G5X+FMB="YC;VT``!X`
M`C !````!0```%--5% `````'@`#, $````9````;6]L+6-A;F-E<D!L:6YU
M>"YK8G0N8V]M``````,`%0P!`````P#^#P8````>``$P`0```!L````G;6]L
M+6-A;F-E<D!L:6YU>"YK8G0N8V]M)P```@$+, $````>````4TU44#I-3TPM
M0T%.0T520$Q)3E58+DM"5"Y#3TT````#```Y``````L`0#H!`````@'V#P$`
M```$`````````UX[`0B !P`8````25!-+DUI8W)O<V]F="!-86EL+DYO=&4`
M,0@!!( !`"L```!213H@2&5P871O8V5L;'5L87(@;&EV97(@8V%N8V5R(&UO
M9&%L:71I97,`OP\!!8 #``X```#,!P$`&P`'`"H`)0`&`$L!`2" `P`.````
MS <!`!L`!P`G`!(`!@`U`0$)@ $`(0```#,V0D$R,CDU-S8U.$-&,3%!,T$S
M-#0T-34S-30P,# P`,T&`0.0!@#H!P``$@````L`(P`!`````P`F```````+
M`"D``0````,`-@``````0 `Y`*#-'U*][+H!'@!P``$````K````4D4Z($AE
M<&%T;V-E;&QU;&%R(&QI=F5R(&-A;F-E<B!M;V1A;&ET:65S```"`7$``0``
M`!8````!NNR]4@^5(KHW6'81SZ.C1$535 `````>`!X,`0````4```!33510
M`````!X`'PP!````#P```&-R<&%G>4!W=V$N8V]M```#``80OQZ:!P,`!Q 0
M!@``'@`($ $```!E````24%-051404-(24Y'05)%4$Q924U!1$543T%.24Y1
M54E264%"3U542$-#34%$14].0T%.0T52+4Q-04E,3$E35%!,14%3149%14Q&
M4D5%5$]#3TY404-4345"641)4D5#5$4M30`````"`0D0`0```%X&``!:!@``
M:0H``$Q:1G5 =+@J_P`*`0\"%0*H!>L"@P!0`O()`@!C: K <V5T,C<&``;#
M`H,R`\4"`'!R0G$1XG-T96T"@S.W`N0'$P*#-!+,%,5]"H _",\)V0* "H$-
ML0M@;F=X,3 S%% +"A5B`= @<$D@86T;``) `-!HM0N 9QL`(!>@"U!Y&N'C
M`, -L"!T;QL``Z +@/!Q=6ER'$ !H A@!4"82$-#''0"("!#`'"Z8P20+0,@
M`, #$6P$`(!T+B!0;&5A$;#\(&8)X ,@`U )X!S"!:!/`C `T 5 !X @8AQ 
M9&<=< 60!4!E+1]C!I @RGD(8" #\6@N"H4*CST:6%<@H 6@(=$<T71H1QRP
M'[(%T&EK91_P62,C42(P9&XG!4!G:<IV'+!U!"!M=1%P',)F9QS@'J%E>!\`
M!3$B.0N ;W $D &@(" N(LT:X7<@0"(A86<J,!&P'F0=(091!3 ?\"<Y-5\C
M<2:@'@`<$!M ;Q\`;,\*0 M@!< >T')C*B$`P.P@*"T4`, I'/$KT!S05FPK
MT"(!;1Q 1QKP9*<M8!S""?!J;QQ =Q& _05 = =Q&N$1@"O0(" !@-@@+2 1
MX!S1-AQP`B&4:',?\%0FL4Y#&O#W'[ 3T"IP= AP'+ $`"*0_RA@`Z $8#2A
M#; 34 >0`)!?&5 ?\#'D!0`C0',(<&?_!) <0 M@)P$S(R]#*Q,%D/LMP2O!
M8Q[C(,0Q0#4A- 'K,E(FHF@KH' LT = ,X/W-*$X\1QQ;B_Q/%(-L &0LP,0
M!"!))R_!'+!G"V!]+W(@(Z \`BS#(T(K(7=?+8$_,B:B-=$ML'0$(&__(R I
MH!& *) QD"AA-=$@,+\N("CP,%$GX!Z2)J)N$<#M+T-O)J$%P',(81\`,W'^
M1342(Q41@"AA*,! < 4@^R @',!U-5$$(#;*.4$]DO\HD"O$/$,Y0!&P/]$<
MX # _R=0)I,A42(P,9 >H2I&(4+_-1%)X@= '# [BA&P*& J</\#("I 2>)(
MLR%1`) $@2'P[QWA+- TP@=P<!=!`' Q<><<X2&A'5%C:QPQ*R$>$M\TT1O@
M(' WD@G ;P/P&[';.40?\$0<X"-":RHP!^#_,4,3P"MP'+ C007 .44TT?<R
MD$Z2!4!U`P`"$#E `R#^* (@1>4O, 6Q17,?``(P_P40,) RD#%#/ (FH@> 
M($!_-)$'@ (P0)-3XR[Q!; H_G,O,%>B'$!4]$V6*\-*-_]4UD+P"L$%L0K 
M"& O80.1[PK -$$<0 6Q8@,0-8$HT/] @536)B$+4$_P&T KP2(!^2XP<G([
M`331!;$FL"TQ_TG15+)%(T3D7>%,44F2%+#\3D0;T2:@'7!"83LP`P#_'J$R
MD#;*)G=,@33"0O 'X.\O4F;20W ;`'8?<4IS*_']2V$@)'% A$E455!74!Q 
M^GD1P"Q#P2'1,'$<T$9!]SP"9[(U`V$K$#2A0+%.8?]B85,!--%3XR:P!T L
MX4-S^0/Q93\SDB!19$$94&M4_VC"3LM2XQS13N +@$Y!0I0Y!1!G: 5 (C1)
M\2Y,_T,!(=$@0%C"(S,FH#%A/O3_-*)R&@M1'P!"=B;C,I!#@NT[Z7=)H020
M9BVP.3$%$/\;L2I0*D!%T3NS'-% L"" ]52!;@(0<@# 2>,O4C<`?G!.XE)2
M* (@( 5 4^,B]D8=<"<!5!V *M ]H5/C_S>":H!\PBB1;>$YD@-P/O3F9PMQ
M(\U"=2O0@;$CWX\D[X'_"R$?L#$T- +1/&DMA7,,T(5S"UDQ-N^"@ -@$] A
MH2V(%X)GALOK##"'ED8#83J)'H>6#()(($QO*$!N3AL094!;4TU44#J,UT#,
M;6-S4 6P9UV(OXG-?P9@`C"*_XP+)? G\ >09-1A>6J 2@!P=0K '$!$,C1J
M@#$Y.3,`-&@Z-#,@`$V.[XG-5$YOD2^,"P1@;"TY1$##'["3T'@N:V(?X"8A
MXY4_C_YU8FHB89=?C O_+1UF=#E%!&$'0$G1!Y"$'_\+*!11"_*'EB 5>M0A
MPD"Q_VX!!)%A\45"H-<O1!>@&T#_601Z\:'&8<,M:!-0!W"3\O^?^RS#3N U
M\4J"!X !D%.!_P"02*07,#]PH;=R=!<P/:'_)J-54#8PH6RN[Z&?&AN'APNP
MI1;!`+. ```#`! 0``````,`$1 !````0 `',&#42-N\[+H!0 `(,&#42-N\
9[+H!'@`]``$````%````4D4Z( ````"?F `'
`
end